Translate Bio, Inc. (TBIO) financial statements (2021 and earlier)

Company profile

Business Address 29 HARTWELL AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:189144
Cash and cash equivalents8555
Short-term investments10489
Other undisclosed cash, cash equivalents, and short-term investments (0)
Restricted cash and investments11
Other undisclosed current assets144
Total current assets:204150
Noncurrent Assets
Operating lease, right-of-use asset10
Property, plant and equipment1310
Intangible assets, net (including goodwill)107128
Goodwill2121
Intangible assets, net (excluding goodwill)86106
Other noncurrent assets3 
Total noncurrent assets:133138
TOTAL ASSETS:336288
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2312
Accounts payable165
Accrued liabilities77
Deferred revenue18
Debt1 
Contract with customer, liability3
Total current liabilities:4214
Noncurrent Liabilities
Long-term debt and lease obligation12 
Operating lease, liability12
Liabilities, other than long-term debt129148
Deferred revenue25
Contract with customer, liability42
Deferred rent credit 2
Deferred tax liabilities, net0
Business combination, contingent consideration, liability104104
Total noncurrent liabilities:141148
Total liabilities:183162
Stockholders' equity
Stockholders' equity attributable to parent154125
Common stock00
Additional paid in capital512371
Accumulated other comprehensive income10
Accumulated deficit(359)(246)
Total stockholders' equity:154125
TOTAL LIABILITIES AND EQUITY:336288

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Gross profit:81
Operating expenses(124)(106)
Operating loss:(116)(104)
Nonoperating income21
Investment income, nonoperating21
Loss from continuing operations before income taxes:(114)(103)
Income tax benefit06
Net loss attributable to parent:(113)(97)
Preferred stock dividends and other adjustments (1)
Net loss available to common stockholders, diluted:(113)(98)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(113)(97)
Comprehensive loss:(113)(97)
Other undisclosed comprehensive income, net of tax, attributable to parent10
Comprehensive loss, net of tax, attributable to parent:(113)(97)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: